Jun. 09, 2014

Bruce Richardson is Second Recipient of the Lupus Insight Prize

Dr. Richardson’s work has provided a strong foundation from which further advances in the understanding and treatment of lupus can be made.

Apr. 07, 2014

Lupus Foundation of America and BMJ Publish First Open Access Journal Dedicated To Lupus

The Lupus Foundation of America and BMJ recently announced the launch and publication of the first scientific research articles in Lupus Science & Medicine™.

Mar. 25, 2014

Announcing a New Initiative to Improve Health and Quality of Life

The Lupus Foundation of America is funding and leading the development of a first-of-its-kind tool to monitor lupus disease activity called the LFA-REAL™ (Rapid Evaluation of Activity in Lupus) System. LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential to greatly improve medical care and quality of life for people living with this unpredictable and misunderstood autoimmune disease.

Feb. 20, 2014

UNVEIL Your Experiences with Lupus

The Lupus Foundation of America, in partnership with Eli Lilly and Company and the research firm ICON plc, is conducting an online national research study to better understand the impact of lupus on people with the disease and their caregivers.

Feb. 06, 2014

NIH Announces Partnership to Accelerate Development of New Treatments for Lupus & Other Diseases

The Lupus Foundation of America will partner with the Foundation for the National Institutes of Health (FNIH) to support a new five-year initiative that will accelerate the ability to develop new medicines for lupus and other diverse and complex diseases.

Jan. 14, 2014

Congress Recognizes the Importance of Lupus Research and Programs

What a way to kick off 2014! Last night, the House and Senate appropriators dropped the Omnibus Appropriations bill.

Nov. 15, 2013

Putting Lupus in Permanent Remission

Northwestern Medicine® scientists have successfully tested a nontoxic therapy that suppresses Lupus in blood samples of people with the autoimmune disease. This is a positive step toward one day developing a vaccine-like therapy that could keep Lupus in remission in the human body without the use of toxic drugs.

Nov. 09, 2013

Center for Clinical Trials Education